Press Releases

XORTX Announces Election to Voluntary Delist from the TSX Venture Exchange

XORTX Announces Closing of US$5 Million Public Offering

XORTX Announces US$5 Million Public Offering

XORTX Meets Nasdaq Continued Listing Requirements

XORTX Announces Closing of Acquisition of Vectus Kidney Anti-fibrotic Asset

XORTX Confirms Effective Date of Share Consolidation

XORTX Announces Results of Annual and Special Meeting of Shareholders

XORTX Announces Change of Effective Date of Share Consolidation

XORTX Announces Share Consolidation

XORTX Reports that Shareholders Approved the Share Consolidation at the Annual General Meeting